Publication Details

Pubmed21075308
Title: Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
Year: 2010
DOI: https://doi.org/10.1016/j.ccr.2010.10.025
First Author: Liang
Experimental setup: affinity chromatography technology (Biogrid)
anti bait coimmunoprecipitation (IntAct)
Throughput: Low Throughput (Biogrid)

Interactions

7 interactions